Assessment of primary lymphedema and post-thrombotic lower limb edema patient’s pathway

Bozon G1, Mestre Godin S2, Chorron G3, Nou Howaldt M4, Laroche JP4, LeCollen L4, Calais C4, Quéré I2, Galanaud JP5. J Med Vasc. 2020 Apr;45(2):55-61

Abstract

Assessment of primary lymphedema and post-thrombotic lower limb edema patient’s pathway.

Bozon G1, Mestre Godin S2, Chorron G3, Nou Howaldt M4, Laroche JP4, LeCollen L4, Calais C4, Quéré I2, Galanaud JP5. J Med Vasc. 2020 Apr;45(2):55-61

OBJECTIVES:

To assess: (1) lower limb primary lymphedema or post-thrombotic syndrome patient’s pathway in terms of health care professional use and (2) if aetiology of edema has an impact on this pathway.

METHODS:

Ancillary survey of the transversal prospective CHROEDEM pilot study. Forty patients with either lower limb primary lymphedema or post-thrombotic syndrome were invited to participate.

RESULTS:

Seventy-five percent of primary lymphedema patients and 50% of post-thrombotic patients benefited from a multidisciplinary management (P=0.10) including the general practitioner, the vascular medicine physician and either a physiotherapist (particularly in case of primary lymphedema), a registered nurse (particularly in case of post-thrombotic syndrome). Main ambulatory health care professionals’ correspondent of hospital-based vascular medicine physicians were general practitioners (80%) in post-thrombotic patients, and general practitioners (60%) and physiotherapists (45%) in primary lymphedema patients. Pharmacists were also involved in patient education.

CONCLUSION:

Management of primary lymphedema and post-thrombotic related chronic edema is usually multidisciplinary. General practitioners and vascular medicine physicians are the cornerstones of this management, that also involves the physiotherapist in case of primary lymphedema and in a lesser extent the registered nurse and the pharmacist. This suggests that these five healthcare professional should play a key role in case of development of standardized patient pathways for primary lymphedema and post-thrombotic syndrome.